Programmdetails

Postervorträge

Biomarker – und genetische Diagnostik bei Kardiomyopathien

Freitag, 25. April | 16:00 - 17:00 Uhr | Posterbereich 20

Vorsitz/Chair: Melanie Ricke-Hoch (Hannover), Susanne Rohrbach (Gießen)

Agenda

(P1322)
Patients with genetic cardiomyopathies exhibit a profile of heart-reactive antibodies distinct from the general population
D. Göpfert (Würzburg)
(P1323)
Chronic activation of the Anrep effect in regulating myocardial contractility in patients with obstructive hypertrophic cardiomyopathy
K. Peters (Bad Oeynhausen)
(P1324)
Real-world efficacy in patients with hypertrophic obstructive cardiomyopathy undergoing myosin inhibitor therapy: Clinical characteristics of incomplete hemodynamic and symptomatic responders
K. Seuthe (Köln)
(P1325)
Non-invasive Atrial Cardiomyopathy Diagnosis - How You Measure The P-wave Duration Matters
S. Becker (Bad Krozingen)
(P1326)
Identification of Regulatory Elements and Key Genes Associated with Dilated Cardiomyopathy in Left Ventricular Tissue Using Chromatin Interaction and Multi-Omics Integration
A. Muñoz Verdú (Heidelberg)
(P1327)
Role of Protein Kinase D1-mediated NLRP3 Activation in Pathogenesis of Sepsis-induced Cardiomyopathy
M. Ghait (Greifswald)
(P1328)
Atlas of cardiomyopathy associated DES (desmin) mutations: Focus on the 1B domain
A. Brodehl (Bad Oeynhausen)
Diese Seite teilen